06:51 AM EST, 01/28/2025 (MT Newswires) -- Lantheus Holdings Inc ( LNTH ) said Tuesday that it entered a definitive agreement to acquire Evergreen Theragnostics in an all-cash transaction.

The transaction will consist of an upfront payment of $250 million and up to an additional $752.5 million in potential milestone payments, the company said.

The acquisition has been approved by the boards of directors of both companies and is expected to close in the second half of 2025.

Lantheus ( LNTH ) reaffirmed its 2024 financial guidance. The company previously said it expects 2024 adjusted EPS of between $6.65 and $6.70 on revenue of between $1.51 billion and $1.52 billion.